NCT02017288

Brief Summary

Background: \- Cancer of the mouth and throat is one of the most common cancers in Taiwan. This cancer develops over several years, beginning as white or red patches in the mouth or throat that become growths. It can also cause a condition that leads to rigidity of the cheeks. The growths can be identified when a doctor looks into a person s mouth. It is currently not clear why some people with abnormal growths progress to cancer while others do not. Researchers want to better understand why some patients with early abnormal growths get late abnormal growths. They also want to understand why some people get abnormal growths again, even after they receive treatment. Objectives: \- To understand why some people with precancerous lesions in their mouth develop cancer while others do not. Eligibility: \- Adults 21 years and older, some with abnormal growths in the mouth, some without any, and some with head and neck cancer. Design:

  • Participants will visit a hospital in Taiwan 2 times.
  • At the first visit, participants will answer questions about their health, lifestyle, and family medical history. A doctor will examine the participant s mouth and take a small piece of any growth they see. They will do this with a brush. They will also photograph the participant s mouth. Participants will also give blood and saliva samples, plus a small sample of a mouth rinse.
  • Participants who are diagnosed with a late abnormal growth that is not cancer will return for a second visit. They will answer the same questions and undergo the same procedures as at the first study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,576

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2013

Longer than P75 for all trials

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 18, 2013

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 19, 2013

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 20, 2013

Completed
7.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 4, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 4, 2021

Completed
Last Updated

February 8, 2021

Status Verified

February 1, 2021

Enrollment Period

7.2 years

First QC Date

December 19, 2013

Last Update Submit

February 4, 2021

Conditions

Keywords

Head and Neck CancersLarynxOropharynxOral Cavity

Outcome Measures

Primary Outcomes (1)

  • Progression to dysplasia/cancer in participants with oral precursors.

    Histologically confirmed progression to dysplasia/cancer in participants with oral precursors.

    Follow-up visits every 6 months for 5 years

Study Arms (3)

Cancer

Participants diagnosed with incident oral cancer

Control

Participants without oral lesions or cancers matched to oral cancer/precursor participants on age, gender, smoking/betel nut habits

Precursor

Participants clinically diagnosed with oral lesions

Eligibility Criteria

Age21 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A prospective cohort study of 3000 patients with precursors to investigate the natural history of histologically-defined oral cancer precursor lesions and evaluate epidemiologic/ molecular predictors for progression. This prospective component will be complemented by cross-sectional comparisons of epidemiologic/molecular factors across 750 controls, 3000 precursors, and 750 cancers.

You may qualify if:

  • We plan to recruit all patients (controls, precursors, and invasive cancers) at the aforementioned two hospitals. Doctors at these hospitals conduct routine visual and tactile examination as part of Taiwan s national oral cancer screening program. For this screening program, all individuals aged 21 years or older who chew betel-quid or smoke are screened through visual inspection for the presence of precursor lesions or cancer.

You may not qualify if:

  • Participants younger than 21 years and individuals with a history of head and neck cancer will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Chang Gung Memorial Hospital - Kaohsiung

Kaohsiung City, Taiwan

Location

China Medical University Hospital

Taichung, 40402, Taiwan

Location

National Taiwan University Hospital

Taipei, Taiwan

Location

Chang Gung Memorial Hospital- Taoyuan

Taoyuan District, Taiwan

Location

MeSH Terms

Conditions

Head and Neck NeoplasmsLaryngeal Diseases

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsRespiratory Tract DiseasesOtorhinolaryngologic Diseases

Study Officials

  • Anil K Chaturvedi, M.D.

    National Cancer Institute (NCI)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 19, 2013

First Posted

December 20, 2013

Study Start

November 18, 2013

Primary Completion

February 4, 2021

Study Completion

February 4, 2021

Last Updated

February 8, 2021

Record last verified: 2021-02

Locations